Polypharmacy Guidance: appropriate prescribing, making medicines safe, effective and sustainable 2026 - 2029
Updated polypharmacy prescribing guidance. 'Appropriate Prescribing - Making medicines safe, effective and sustainable 2025-2028' aims to further improve the care of individuals taking multiple medicines through the use of 7-Steps medicine reviews and promotes a holistic approach to person-centred c
10. Abbreviations
ACB Anticholinergic burden
ACBS Anticholinergic Cognitive Burden scale
ACE Angiotensin Converting Enzyme
ACEI Angiotensin Converting Enzyme Inhibitor(s)
Ach Acetylcholine
AChEI Acetylcholinesterase Inhibitors
ACS Acute Coronary Syndrome
ADR Adverse Drug Reaction
AF Atrial Fibrillation
AI Artificial Intelligence
AKI Acute Kidney Injury
AMR Antimicrobial Resistance
ARB Angiotensin II Receptor Antagonist
ARS Anticholinergic Risk Scale
ASB Asymptomatic Bacteriuria
ASCVD Atherosclerotic Cardiovascular Disease
ASM Antiseizure Medications
ASSIGN ASsessing cardiovascular risk using SIGN guidelines to assign preventive treatment
AWI Adult With Incapacity
BMD Bone Mineral Density
BMI Body Mass Index
BNF British National Formulary
BNP Brain Natriuretic Peptide Test
BP Blood Pressure
BPM Beats per Minute
BZ Benzodiazepine
CBT Cognitive Behavioural Therapy
CCBs Calcium Channel Blockers
C. diff Clostridioides difficile
CGA Comprehensive Geriatric Assessment
CHA2DS2-VASc Score for Atrial Fibrillation Stroke Risk
CHD Coronary Heart Disease
CHF Congestive Heart Failure
CHI Community Health Index
CI Confidence Interval
CKD Chronic Kidney Disease
CNS Central Nervous System
COMT Catechol-O-methyl Transferase
COPD Chronic Obstructive Pulmonary Disease
COWS Clinical Opiate Withdrawal Scale
CrCl Creatinine Clearance
CSCI Continuous subcutaneous infusion
CVD Cardiovascular Disease
DAPT Dual Antiplatelet Treatment
DBP Diastolic Blood Pressure
DKA Diabetic Ketoacidosis
DMARDs Disease-modifying anti-rheumatic drugs
DN4 Douleur Neuropathique 4
DOAC Direct Acting Oral Anticoagulant
DPP-4i Dipeptidyl Peptidase 4 Inhibitors
DQIP Data-Driven Quality Improvement in Primary Care
DVT Deep Venous Thrombosis
DXA Dual-energy X-ray Absorptiometry
ECG Electrocardiogram
ECHO Echocardiogram
eDKA euglycaemic Diabetic Ketoacidosis
eGFR Estimated Glomerular Filtration Rate
ECOG Eastern Cooperative Oncology Group
EMIS Egton Medical Information Systems – a clinical IT system
EU European Union
EuGMS European Geriatric Medicine Society
g Gram (unit of measurement)
GAD Generalised Anxiety Disorder
GI Gastro-intestinal
GL Guideline
GLP-1RA Glucagon-Like Peptide-1 Receptor Agonists
GP General Practitioner
GTN Glyceryl Trinitrate
HbA1C glycated haemoglobin
HCP Healthcare Professionals
HDAT High-dose antipsychotic therapy
HDL High-density Lipoprotein
hHF Hospitalisation for Heart Failure
HF Heart Failure
HR Heart Rate
HRT Hormone Replacement Therapy
HSCP Health and Social Care Partnership
ICS Inhaled Corticosteroid
IHD Ischaemic Heart Disease
INR International Normalised Ratio
ISD Information Services Division
iSIMPATHY Implementing Stimulating Innovation in the Management of Polypharmacy and Adherence Through the Years
IT Information Technology
IV Intravenous
KIS Key Information Summary
L2 2nd Lumbar Vertebrae
LFTs Liver Function Tests
LGS Lennox-Gastaut Syndrome
LOS Length of Stay
LVEF Left Ventricular Ejection Fraction
LVSD Left Ventricular Systolic Dysfunction
MACE Major Adverse Cardiovascular Events
MAI Medication Appropriateness Index
MAO-B Monoamine Oxidase type B
MAOIs Monoamine Oxidase Inhibitors
mARS modified Anticholinergic Risk Scale
MCA Multi-compartment Compliance Aid
MDT Multidisciplinary Team
MED Morphine Equivalent Dose
mg Milligram (unit of measurement)
MHRA Medicines and Healthcare products Regulatory Agency
MI Myocardial Infarction
MMSE Mini-Mental State Examination
MRI Magnetic Resonance Imaging
MRSA Methicillin Resistant Staphylococcus Aureus
NCSE Non-convulsive Status Epilepticus
NES NHS Education for Scotland
NHS National Health Service
NICE The National Institute for Health and Care Excellence
NMDA N-methyl-D-aspartate
NMS Neuroleptic Malignant Syndrome
NNH Number Needed to Harm
NNT Number Needed to Treat
NOGG National Osteoporosis Guideline Group
Non-STEMI Non ST-elevation myocardial infarction
NSAID Non-steroidal anti-inflammatory drugs
NTI National Therapeutic Indicator
NYHA New York Heart Association (Functional Classification)
OCD Obsessive-Compulsive Disorder
OTC Over the counter
PADL Penicillin allergy de-labelling
PC-MAI Person-Centred Medication Appropriateness Index
PD Parkinson’s Disease
PE Pulmonary Embolism
PESTEL Political, Economic, Social, Technological, Environmental, and Legal
PGx Pharmacogenomics
PIMs Potentially inappropriate medications
PIS Prescribing Information System
pMDI pressurised Metered Dose Inhalers
PNS Peripheral nervous system
POA Power of Attorney
PPIs Proton Pump Inhibitors
PROMs Patient Reported Outcome Measures
PTSD Post-Traumatic Stress Disorder
QALY Quality Adjusted Life Year
QT interval the time measured on a electrocardiogram from the start of the Q wave to the end of the T wave correlating with the time taken from the beginning to end of ventricular contraction and relaxation
QTc Corrected QT Interval
SABA short-acting beta2 agonist
SALT Speech and Language Therapy
SAPG Scottish Antimicrobial Prescribing Group
SBP Systolic Blood Pressure
SC Subcutaneous
SGLT-2i Sodium-Glucose Co-Transporter 2 inhibitor
SIGN Scottish Intercollegiate Guidelines Network
SIMD Scottish Index of Multiple Deprivation
SIMPATHY Stimulating Innovation Management of Polypharmacy and Adherence in the Elderly
S-LANSS Self-reported Leeds Assessment of Neuropathic Symptoms and Signs
SMC Scottish Medicines Consortium
SMR01 Scottish Morbidity Record (Covers General Acute Inpatient and Day)
SNRI Serotonin Norepinephrine Reuptake Inhibitors
SPARRA Scottish Patients at Risk of Re-admission or admission
SPC Summary of Product Characteristics
SPICT Supportive and Palliative Care Indicator Tool
SR Systematic Review
SSDD Symptoms of stress and distress in dementia
SSRI Selective Serotonin Reuptake Inhibitors
START Screening Tool to Alert to Right Treatment
STEADI Stopping Elderly Accidents, Deaths and Injuries
STEMI ST-elevation myocardial infarction
STOPP Screening Tool of Older People's Prescriptions
STOPPFall Screening Tool of Older Persons Prescriptions in older adults with high fall risk
STU Scottish Therapeutics Utility
SWOT Strengths, Weaknesses, Opportunities and Threats
T Score Bone Density Score
T2DM Diabetes Mellitus Type 2
TCA Tricyclic Antidepressants
TFT Thyroid Function Test
TURAS NES’ digital platform for Health and Social Care professionals
U&E Urea & Electrolyte Profile
UK United Kingdom
USA United States of America
UTI Urinary Tract Infection
VRE Vancomycin-Resistant Enterococcus
Contact
Email: epandt@gov.scot